Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Barcelona
Clinical trial register · Spain

Clinical Trials in Barcelona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca188 Merck Sharp & Dohme LLC113 Novartis Pharmaceuticals111 Janssen Research & Development, LLC96 Hoffmann-La Roche85
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Barcelona

3238 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
Hoffmann-La Roche
Phase 3
257
Barcelona, Madrid, Seville, Valencia
2018-08-16
Active, closed
Gilead Sciences
Phase 2
502
Badalona, Barcelona, Córdoba, Las Palmas, Madrid, Majadahonda, Manresa, Ourense
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Puerto Real, Alicante, Barcelona, Madrid
2018-08-09
Recruiting
Sanofi
Phase 2
51
Esplugues de Llobregat, Barcelona, Madrid, Málaga, Valencia
2018-08-09
Active, closed
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
Grupo Español Multidisciplinar de Melanoma
Observational
400
Alcoy, Granada, Málaga, Barcelona, Sabadell, Vitoria-Gasteiz, Santander, Burgos
2018-08-07
By invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
NCT03628612Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric
Autolus Limited
Phase 2
500
Barcelona
2018-08-02
Active, closed
AstraZeneca
Phase 3
216
Barcelona, Madrid, Málaga, San Sebastián, Seville, Valencia
2018-07-19
Recruiting
Celgene
Phase 2/3
1,541
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Málaga, Pamplona, Salamanca, Santander
2018-07-19
Active, closed
PETHEMA Foundation
Phase 2
62
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona
2018-07-15
Active, closed
Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
NCT04737135Congenital Heart Disease, Congenital Heart Defect, Fallot Tetralogy
Hospital Universitari Vall d'Hebron Research Institute
Observational
224
Madrid, Barcelona, Seville, Valencia
2018-07-09
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Pamplona, Badalona, Barcelona, Madrid
2018-06-26
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Barcelona, Manresa, Madrid
2018-06-25
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Badalona, Ávila, Alcorcón, Barcelona, Burgos, Madrid, Murcia, Seville
2018-06-21
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
732
Oviedo, Madrid, Barcelona, Castellon, Seville, Valencia
2018-06-19
Active, closed
Exelixis
Phase 3
837
Santander, Majadahonda, Pamplona, Barcelona, Madrid, Valencia, Zaragoza
2018-06-10
Active, closed
Genentech, Inc.
Phase 1
123
Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2018-06-06
Recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Observational
40
Barcelona
2018-06-06
Recruiting
Fundació Sant Joan de Déu
Observational
90
Esplugues de Llobregat, Barcelona
2018-06-01
Active, closed
Canadian Cancer Trials Group
Phase 2
129
Pamplona, Barcelona, Madrid, Valencia
2018-05-28
Active, closed
Hoffmann-La Roche
Phase 3
927
Barcelona, Murcia, Valencia
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pamplona, Badalona, Barcelona, Madrid, Santiago de Compostela
2018-05-21
Recruiting
BioInvent International AB
Phase 1/2
140
Badalona, Barcelona, Madrid, Murcia, Seville
2018-05-16
Active, closed
pharmaand GmbH
Phase 3
1,097
Barcelona, Bilbao, Castillón, El Palmar, Jerez de la Frontera, Madrid, Oviedo, Palma de Mallorca
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Alicante, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Valencia, Vigo
2018-05-14
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Barcelona, Madrid, Málaga, Valencia
2018-05-08
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Barcelona, Castellon, Donostia / San Sebastian, Girona, Madrid, Vigo
2018-05-03
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Barcelona, Madrid, Pamplona, Zaragoza
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Merus B.V.
Phase 1/2
560
Barcelona, Madrid, Pamplona, Valencia
2018-05-02
Active, closed
Longitudinal Early-onset Alzheimer's Disease Study Protocol
NCT03507257Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
DrugsFlorbetaben·Fluorodeoxyglucose
Indiana University
Observational
850
Barcelona
2018-04-30
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Barcelona
2018-04-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Active, closed
MedImmune LLC
Phase 1
400
A Coruña, Barcelona, Majadahonda, Málaga, Pamplona, Valencia
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Badalona, Esplugues de Llobregat, Barcelona, Madrid, Tortosa
2018-04-23
Recruiting
Fundació Institut Germans Trias i Pujol
Observational
200
Badalona, Esplugues de Llobregat, Barcelona
2018-04-19
Active, closed
Bristol-Myers Squibb
Phase 3
545
Barcelona, Córdoba, Donostia / San Sebastian, Madrid, Pamplona, Sabadell (Barcelona), Seville, Valencia
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Barcelona, Madrid, Pamplona, Salamanca, Seville
2018-04-17
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
L'Hospitalet de Llobregat, Castellon, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Valencia
2018-04-17
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
55
Barcelona, Madrid
2018-04-11
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
A Coruña, Barcelona, Madrid, San Sabastian Gipuzkoa, Seville
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Barcelona, Madrid
2018-04-09
Active, closed
AbbVie
Phase 3
1,336
Ferrol, L'Hospitalet de Llobregat, Sabadell, Majadahonda, Bilbao, Barcelona, Madrid, Salamanca
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
Y-mAbs Therapeutics
Phase 2
122
Barcelona, Madrid, Seville, Valencia
2018-04-03
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
Seville, Barcelona, Madrid
2018-03-30
Active, closed
BioLineRx, Ltd.
Phase 3
180
Barcelona, Madrid
2018-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Badajoz, Badalona, Barcelona, Cáceres, Córdoba, Granada, Jaén, Las Palmas de Gran Canaria
2018-03-23
Active, closed
AbbVie
Phase 3
747
Palma de Mallorca, Santander, Las Palmas de Gran Canaria, Pamplona, A Coruña, Barcelona, Girona, Huelva
2018-03-21
Active, closed
AstraZeneca
Phase 2
154
Barcelona, Madrid, Málaga, Santiago de Compostela
2018-03-16
Active, closed
Eli Lilly and Company
Phase 3
533
Barcelona, Seville, Valencia, Valladolid
2018-03-14
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Barcelona, Madrid, Málaga
2018-03-02
Recruiting
Octapharma
Observational
200
Alicante, Barcelona, Málaga, Palma de Mallorca, Valencia
2018-02-13
Recruiting
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
400
Barcelona
2018-02-12
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Barcelona, Madrid, Valencia
2018-01-26
Recruiting
M.D. Anderson Cancer Center
Observational
260
Barcelona
2018-01-12
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Alicante, Barcelona
2018-01-07
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Barcelona, Madrid, Valladolid
2018-01-01
Active, closed
Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation
NCT06965036Acute Ischemic Stroke Related to Tandem Occlusion, Acute Ischemic Stroke Due to Isolated Cervical Artery Occlusion
Azienda Unità Sanitaria Locale della Romagna
Observational
2,880
Barcelona
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Badalona, Barcelona, Santander, Madrid, Seville, Valencia
2017-12-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Barcelona, Madrid, Seville
2017-12-28
Active, closed
Amgen
Phase 1
269
Barcelona, Madrid
2017-12-26
Active, closed
AstraZeneca
Phase 2
528
Barcelona, Madrid, Seville
2017-12-18
Active, closed
Pfizer
Phase 3
1,054
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Sabadell, El Palmar, Barcelona, Madrid
2017-12-18
Active, closed
Gilead Sciences
Phase 3
340
Badalona, Barcelona, Horcajo de la Sierra, Madrid, Málaga, Santander
2017-12-12
Active, closed
BioMarin Pharmaceutical
Phase 3
119
Barcelona, Málaga
2017-12-12
Active, closed
Sanofi
Phase 3
475
Barcelona, Madrid, Murcia
2017-12-07
Active, closed
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
112
Barcelona, Madrid, Oviedo
2017-11-27
Active, closed
Genentech, Inc.
Phase 1
181
L'Hospitalet de Llobregat, Barcelona, Madrid, Valencia
2017-11-24
Active, closed
BeiGene
Phase 3
590
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Valencia, Zaragoza
2017-10-31
Active, closed
Daiichi Sankyo
Phase 1
312
Barcelona, Madrid, Pamplona
2017-10-30
Active, closed
ViiV Healthcare
Phase 3
1,049
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2017-10-27
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Barcelona, Sabadell
2017-10-26
Recruiting
Italfarmaco
Phase 2/3
206
Esplugues de Llobregat, Barcelona, Seville, Valencia
2017-10-24
Active, closed
AstraZeneca
Phase 3
1,324
Barcelona, Madrid, Oviedo, Pamplona Madrid, Santander
2017-10-11
Recruiting
Apollomics Inc.
Phase 2
497
Badalona, Barcelona, Madrid, Valencia
2017-09-27
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Alcorcón, Barcelona, Bilbao, Cartagena, Córdoba, Las Palmas de Gran Canaria, Pamplona, Sabadell
2017-09-25
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
L'Hospitalet de Llobregat, Santiago de Compostela, Pamplona, Alicante, Barcelona, Madrid, Málaga, Seville
2017-09-22
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Barcelona, Madrid, Málaga, Pamplona, San Cristóbal de La Laguna, Seville, Valencia
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 3
382
Palma de Mallorca, Córdoba, A Coruña, Las Palmas de Gran Canaria, Pamplona, Barcelona, Cáceres, Jaén
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Barcelona, Madrid, Murcia, Pamplona, Seville, Valencia
2017-09-20
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo
2017-09-12
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
NCT04706234Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy, Motor Neuron Disease
Kliniken Beelitz GmbH
Observational
350
Barcelona
2017-09-01
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Donostia / San Sebastian, Barcelona, Madrid, Seville, Valencia
2017-08-23
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Barcelona, Lleida, Seville
2017-08-21
Recruiting
Advenchen Laboratories, LLC
Phase 3
325
Barcelona
2017-08-15
Active, closed
Asthma Research in Children and Adolescents
NCT04480242Persistent Asthma, Asthma in Children, Asthma Exacerbation
Parc de Salut Mar
Observational
525
Cadiz, Seville, Zaragoza, Alava, Torrelavega, Barcelona, Madrid, Valencia
2017-07-26
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 2
120
Barcelona, Madrid, Salamanca, Zaragoza
2017-07-26
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
Hoffmann-La Roche
Phase 2
316
Sant Cugat del Vallès, Donostia / San Sebastian, Alcorcón, Pamplona/iruña, Barcelona, Madrid, Seville
2017-06-27
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Santiago de Compostela, Palma de Mallorca, Badalona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville, Valencia
2017-06-26
Active, closed
MedSIR
Phase 2
377
Badalona, L'Hospitalet de Llobregat, Castelló, Jaén, Málaga, Reus, A Coruña, Barcelona
2017-06-26
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Barcelona, Madrid, Murcia, Salamanca, Seville, Valencia
2017-06-26
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Barcelona, Madrid, Málaga, Murcia, Navarro, Salamanca, Santiago, Seville
2017-06-21
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Badalona, Majadahonda, Barcelona, Madrid, Salamanca
2017-05-22
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Badalona, Barcelona, Pamplona, Salamanca
2017-05-16
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
L'Hospitalet de Llobregat, Barcelona, Elche, Girona, Madrid, Málaga, Valencia, Valladolid
2017-05-03
Active, closed
Eli Lilly and Company
Phase 1/2
857
Barcelona, Madrid
2017-05-02
Active, closed
Göteborg University
Observational
72
Barcelona
2017-05-01
Active, closed
Pfizer
Phase 3
296
L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Majadahonda, Pamplona, A Coruña, Barcelona, Girona, Madrid
2017-04-27
Active, closed
Acerta Pharma BV
Phase 3
635
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Seville, Valencia
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
A Coruña, Barcelona, Madrid, Santander, Seville, Valencia
2017-03-24
Recruiting
Italian Sarcoma Group
Not applicable
100
Barcelona, Madrid, Seville, Valencia
2017-03-16
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Barcelona, Madrid, Pamplona, Valencia
2017-03-07
Recruiting
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
570
Barcelona
2017-03-01
Active, closed
European Association of Urology Research Foundation
Observational
1,054
Barcelona, Granada, Madrid, Murcia, San Cristóbal de La Laguna, Valencia
2017-02-22
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Badalona, L'Hospitalet de Llobregat, Santander, Barcelona, Madrid
2017-02-21
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Barcelona, Madrid, Seville
2017-02-16
Active, closed
AbbVie
Phase 3
443
Pamplona, Barcelona, Madrid, Málaga, Valencia
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Barcelona, Madrid, Oviedo, Valencia
2017-02-02
Active, closed
AbbVie
Phase 3
950
A Coruña, Santiago de Compostela, Santander, Las Palmas de Gran Canaria, Barcelona, Córdoba, Madrid, Salamanca
2017-01-31
Active, closed
AbbVie
Phase 2
120
Badalona, Barcelona, Madrid
2017-01-19
Recruiting
University College, London
Observational
2,500
Bilbao, Barcelona, Madrid
2017-01-01
Active, closed
IRCCS San Raffaele
Observational
1,402
Barcelona
2017-01-01
Active, closed
AstraZeneca
Phase 1
117
Badalona, Barcelona, Madrid
2016-12-28
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Barcelona, Girona, Madrid, Pamplona, Salamanca, Santiago de Compostela
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
A Coruña, Barcelona, Córdoba, Fuenlabrada, Huelva, Madrid, Majadahonda, San Sebastián de los Reyes
2016-12-16
Active, closed
Genentech, Inc.
Phase 1
200
Barcelona, Valencia
2016-12-13
Active, closed
Universitätsmedizin Mannheim
Phase 3
314
Barcelona, Córdoba
2016-12-09
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Barakaldo, Barcelona, Madrid, Oviedo, San Sebastián, Seville, Valladolid, Vigo
2016-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Active, closed
Eli Lilly and Company
Phase 1
223
Barcelona, Madrid, Valencia
2016-11-21
Active, closed
ViiV Healthcare
Phase 3
618
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
A Coruña, Barcelona, Bilbao, Elche Alicante, Ferrol, Granada, La Laguna Santa Cruz, Madrid
2016-10-27
Active, closed
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
419
Barcelona
2016-10-25
Active, closed
Celgene
Phase 1/2
466
Badalona (Barcelona), Barcelona, Madrid, Pamplona, Valencia
2016-10-14
Active, closed
Eisai Inc.
Phase 3
1,069
Santander, Barcelona, Cáceres, Córdoba, Madrid, Oviedo, Seville, Valencia
2016-10-13
Active, closed
Profound Medical Inc.
Not applicable
150
Barcelona
2016-09-21
Active, closed
Eli Lilly and Company
Phase 2
234
Barcelona, Madrid, Valencia
2016-09-14
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Barcelona, Cartagena, Jerez de la Frontera, Madrid, Málaga, San Sebastián de los Reyes, Sant Cugat del Vallès, Seville
2016-09-13
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Barcelona, Madrid, Valencia
2016-08-03
Recruiting
Thoracic Tumours Register
NCT02941458Thoracic Tumors
Spanish Lung Cancer Group
Observational
10,000
Ferrol, Albacete, Alcoy, Alicante, Elche, Elda, Badalona, Barcelona
2016-07-21
Active, closed
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
NCT02489006Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant Treatment, Debulking Surgical Procedures
DrugOlaparib
University Health Network, Toronto
Phase 2
71
Barcelona
2016-07-19
Active, closed
Tesaro, Inc.
Phase 3
733
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Elche Alicante, Girona, Madrid, Seville
2016-07-11
Active, closed
Tesaro, Inc.
Phase 1
463
Barcelona, Girona, Jerez de la Frontera, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Málaga, Palma de Mallorca
2016-07-08
Active, closed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
NCT02716116Carcinoma, Non-Small-Cell Lung
DrugMobocertinib
Takeda
Phase 1/2
334
A Coruña, Barcelona
2016-06-16
Recruiting
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
NCT04005976Aortic Aneurysm, Aortic Dissection, Aortic Diseases
The University of Texas Health Science Center, Houston
Observational
5,000
Barcelona
2016-06-15
Active, closed
Celgene
Phase 1/2
130
Barcelona, Cáceres, Madrid, Málaga, Valencia
2016-06-03
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Barcelona, Palma de Mallorca
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
A Coruña, Barcelona, Madrid, Málaga, Santander, Seville
2016-05-24
Active, closed
Eli Lilly and Company
Phase 2
309
L'Hospitalet de Llobregat, Barcelona, Madrid
2016-05-19
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Active, closed
NeuroDerm Ltd.
Phase 2
214
Barcelona, Madrid
2016-05-04
Recruiting
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
NCT02716246MPS IIIA, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis III
Ultragenyx Pharmaceutical Inc
Phase 2/3
36
Barcelona, Santiago de Compostela
2016-04-25
Recruiting
UMC Utrecht
Phase 3
20,000
Barcelona, Cadiz, Córdoba, Madrid, Málaga, Ourense, Santander, Tortosa
2016-04-11
Active, closed
Tesaro, Inc.
Phase 1
729
Santiago de Compostela, Barcelona, Girona, Madrid, Málaga, Murcia, Pamplona, Santander
2016-03-07
Recruiting
Boston Scientific Corporation
Observational
300
Barcelona, El Palmar, Madrid, Oviedo
2016-03-07
Active, closed
MedImmune LLC
Phase 1/2
383
Barcelona, Madrid, Málaga, Pamplona, Seville
2016-02-22
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 1
23
Barcelona, Seville
2016-02-12
Recruiting
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
NCT02817360Heart Diseases, Diabetes Mellitus, Type 2
Martin Huelsmann
Phase 4
2,400
Barcelona
2016-02
Active, closed
Geron Corporation
Phase 2/3
289
Cadiz, Majadahonda, Seville, Valencia, Barakaldo, Badalona, Barcelona, Madrid
2016-01-12
Recruiting
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
NCT06767605Hepatitis Autoimmune Disease, Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Cholestatic Genetic Diseases
Asociación Española para el Estudio del Hígado
Observational
5,000
Barcelona
2016-01-01
Active, closed
Bayer
Phase 1/2
154
Barcelona
2015-12-16
Active, closed
Novartis Pharmaceuticals
Phase 4
233
A Coruña, Barcelona, Madrid, Málaga
2015-12-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Barcelona, Córdoba, Jerez de la Frontera, Madrid, Pamplona
2015-11-27
Active, closed
Hoffmann-La Roche
Phase 2
534
Fuenlabrada, Barcelona, Madrid, Málaga, Seville
2015-11-19
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Barakaldo, Barcelona, Castellon, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Reus
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Esplugues, L'Hospitalet de Llobregat, Pamplona, Barcelona, Madrid, Salamanca, Seville, Valencia
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
A Coruña, Barcelona, Donostia / San Sebastian, Elche, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2015-10-21
Active, closed
MedImmune LLC
Phase 2
433
Barcelona, Córdoba, Pamplona
2015-10-19
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Barcelona, Madrid, Pamplona, Sabadell, Salamanca
2015-10
Active, closed
JOURNEY™ II CR Total Knee System
NCT02440672Osteoarthritis, Knee
Smith & Nephew, Inc.
Observational
170
Barcelona
2015-09
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Barcelona, Madrid, Murcia
2015-08-06
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
A Coruña, Alicante, Badalona, Barcelona, Burgos, Castellon, Cáceres, Córdoba
2015-08
Active, closed
Acerta Pharma BV
Phase 3
533
Barcelona, Madrid, Majadahonda, Murcia, Santander
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,118
A Coruña, Alicante, Barcelona, Girona, Jaén, León, Madrid, Majadahonda
2015-07-21
Recruiting
Maurizio Tonetti
Not applicable
160
Barcelona
2015-07-12
Active, closed
Medtronic
Observational
3,100
A Coruña, Barcelona, Santiago de Compostela, Toledo, Vitoria-Gasteiz
2015-07
Active, closed
Acerta Pharma BV
Phase 3
535
Barcelona, Madrid, Majadahonda, Santander
2015-06-26
Recruiting
University Hospital, Geneva
Observational
20,000
Barcelona
2015-06-01
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Barcelona
2015-05-27
Active, closed
Eli Lilly and Company
Phase 3
545
Barcelona, Hospitalet, Palma, Pozuelo de Alarcón, Madrid, Pamplona, Seville, Valencia
2015-05-06
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Barcelona, Donostia / San Sebastian, Majadahonda, Santander, Seville, Valladolid
2015-05-01
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Barcelona
2015-05-01
Active, closed
PETHEMA Foundation
Phase 2
90
Barcelona, Madrid, Murcia, Oviedo, Pamplona, Plama de Mallorca, Salamanca, Santa Cruz de Tenerife
2015-05
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
NCT02381886Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals
Phase 1
166
Barcelona
2015-03-06
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Barcelona, Pamplona, Salamanca
2015-03-05
Active, closed
Exelixis
Phase 4
247
Barcelona, Madrid
2015-02-25
Active, closed
ViiV Healthcare
Phase 3
371
Badalona, Barcelona, Madrid, Seville
2015-02-23
Active, closed
Hoffmann-La Roche
Phase 3
154
L'Hospitalet de Llobregat, Santander, San Cristóbal de La Laguna, Bilbao, Barcelona, Valencia
2015-02-02
Active, closed
Icahn School of Medicine at Mount Sinai
Observational
2,145
Barcelona
2015-01-13
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
DrugBispecific
Partner Therapeutics, Inc.
Phase 2
250
Barcelona, Madrid, Pamplona, Valencia
2015-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Palma de Mallorca, Manresa, Santiago de Compostela, Barcelona, Cadiz, Girona, Madrid, Ourense
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
El Palmar, Barcelona, Donostia / San Sebastian, Girona, Madrid, Málaga, Oviedo, Palma
2014-12-04
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Alcorcón, Barcelona, Cadiz, Córdoba, Madrid, San Sebastián de los Reyes, Valencia
2014-11-26
Active, closed
Eli Lilly and Company
Phase 3
493
Badajoz, Barcelona, Donostia / San Sebastian, Lleida, Madrid, Valencia
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Badalona, Barcelona, Madrid, Palma de Mallorca, Pamplona, Salamanca, Seville
2014-11
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
DrugTrabectedin
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Zaragoza, Barcelona, Palma de Mallorca, San Cristóbal de La Laguna, Madrid, Seville
2014-11
Active, closed
Eli Lilly and Company
Phase 3
453
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Valencia
2014-10-03
Recruiting
Cerebellar Mutism Syndrome Study
NCT02300766Infratentorial Neoplasms, Mutism
Copenhagen University Hospital, Rigshospitalet
Observational
2,000
Barcelona
2014-10
Active, closed
Eli Lilly and Company
Phase 3
669
Elche, Barcelona, Lleida, Madrid, Murcia, Valencia
2014-07-22
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Barcelona, Madrid, Seville, Valencia
2014-06
Active, closed
AstraZeneca
Phase 3
1,837
A Coruña, Ávila, Badajoz, Badalona, Barcelona, Castellon, Cáceres, Córdoba
2014-04-22
Recruiting
Jules Bordet Institute
Not applicable
1,000
A Coruña, Barcelona, Castellon, Cáceres, Lleida, Madrid, Seville, Valencia
2014-04
Recruiting
Weill Medical College of Cornell University
Not applicable
600
Barcelona
2014-03-12
Recruiting
Boston Scientific Corporation
Observational
1,500
Barcelona, Madrid, Murcia, Oviedo, Valencia
2014-03-04
Active, closed
Fundacion Clinic per a la Recerca Biomédica
Not applicable
233
Barcelona
2014-01-01
Active, closed
UNICANCER
Phase 3
1,173
Badalona, Barcelona, Girona, Madrid, Manresa, Málaga, Sabadell, Salamanca
2013-11-13
Active, closed
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT01980797Bicuspid Aortic Valve Disease, Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
Boston University
Observational
6,464
Barcelona
2013-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
A Coruña, Badalona, Barcelona, Castellon, Girona, Guadalajara, Jerez de la Frontera, Las Palmas de Gran Canaria
2013-10-14
Active, closed
AstraZeneca
Phase 3
510
Barcelona, Madrid, Málaga, Seville, Vigo(Pontevedra), Zaragoza
2013-09-25
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Barcelona, Córdoba, Girona, Madrid, Pamplona, Valencia
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Barcelona, Córdoba, Hospitalet deLlobregat(Barcelo, Madrid, Valencia
2013-08-26
Active, closed
MedImmune LLC
Phase 2
571
Barcelona, Donostia / San Sebastian, Madrid, Sabadell (Barcelona), Seville
2013-05-17
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Barcelona, Málaga, Murcia, Oviedo
2013-04
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Barcelona, Pamplona, Seville
2013-03-18
Active, closed
Bristol-Myers Squibb
Observational
800
Sant Joan Despí, Barcelona, Madrid, Murcia, Valencia
2013-01-30
Active, closed
Washington University School of Medicine
Phase 2/3
490
Barcelona
2012-12
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
2012-07
Recruiting
TIRCON International NBIA Registry
NCT05522374Neurodegeneration With Brain Iron Accumulation (NBIA), Pantothenate Kinase-associated Neurodegeneration (PKAN), Beta-Propeller Protein-Associated Neurodegeneration (BPAN), Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN)
LMU Klinikum
Observational
2,000
Barcelona
2012-06-14
Active, closed
Eli Lilly and Company
Phase 2
110
Barcelona, Madrid
2012-05-22
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Barcelona, Cadiz, Cartagena, Las Palmas, Logroño, Madrid, Majadahonda, Ourense
2012-04-03
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Pamplona, Barcelona, Madrid
2011-09-21
Active, closed
University Medical Center Groningen
Phase 3
920
Barcelona, L'Hospitalet de Llobregat, Valencia
2011-06-21
Recruiting
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta
Observational
500
Barcelona
2011-05
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
A Coruña, Albacete, Barcelona, Castellon, Cáceres, Donostia / San Sebastian, Girona, Madrid
2011-02-28
Recruiting
International (Pediatric) Peritoneal Biobank
NCT01893710Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Heidelberg University
Observational
500
Barcelona
2011-02-01
Active, closed
Apotransferrin in Atransferrinemia
NCT01797055Congenital Atransferrinemia
Prothya Biosolutions
Phase 2
5
Barcelona
2010-12
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Barcelona, Madrid
2010-12
Active, closed
University Hospital, Basel, Switzerland
Observational
3,500
Barcelona, Madrid
2010-04
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Barcelona, Córdoba, León, Oviedo, Vigo
2010-01-01
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
L'Hospitalet de Llobregat, Badalona, Barcelona, Valencia
2009-09
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Barcelona
2009-07
Recruiting
Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817Alzheimer's Disease
Washington University School of Medicine
Observational
700
Barcelona
2009-01
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Barcelona, Bilbao, Reus, Valencia
2008-12-09
Active, closed
Genentech, Inc.
Phase 2
378
Elche, Jerez de la Frontera, Donostia / San Sebastian, Barcelona, Cáceres, Lleida, Madrid, Zaragoza
2008-10-16
Recruiting
International Registry of Accidental Hypothermia
NCT06200285Accidental Hypothermia
University Hospital, Geneva
Observational
500
Barcelona, Girona
2008-10-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Barcelona
2007-12
Active, closed
Fundacion IMIM
Observational
500
Hospitalet Llobregat,, L'Hospitalet de Llobregat, Sant Cugat del Vallès, San Sebastián, A Coruña, Barcelona, Madrid, Málaga
2003-04
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
A Coruña, Barcelona, Barakaldo, L'Hospitalet de Llobregat, Vigo, Tarragona
2001-07-31
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Badalona, Barcelona, Madrid, Valencia, Vitoria-Gasteiz
1994-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
A Coruña, Barcelona, Alcorcón, Vigo, Seville, Madrid, Sabadell, Valencia
1991-04-01
Recruiting
Medtronic
Observational
20,000
A Coruña, Barcelona, Córdoba, Girona, Granada, Madrid, Palma de Mallorca, Salamanca
1983-01
Rows per page Showing 3001–3238 of 3238
Previous 5 6 7
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/barcelona?page=7

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,238 of those studies with a site in Barcelona.

How many clinical trials are recruiting in Barcelona?

1,669 of the 3,238 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 132 have not yet opened recruitment, 1,365 are active but closed to new participants, and 72 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.